Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB:TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed, today announced its operating and financial results for the fourth

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- First graph, end of second sentence of release should read: ...starting at 8:00 am Eastern Time the same day. (sted ...starting at 1:00 pm Eastern Time the same day.). The corrected release reads: TRANSENTERIX SCHEDULES FOURTH QUARTER AND FULL YEAR

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB:TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets 2014 Healthcare

Multiple surgeons perform general surgery procedures in pre-clinical testing RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (OTCBB: TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today

Company to trade under new ticker symbol TRXC RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- SafeStitch Medical, Inc. (OTCBB:SFES) (OTCBB:TRXC), which recently merged with TransEnterix, Inc. , announced the company's name has been changed to TransEnterix, Inc.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- SafeStitch Medical, Inc. (OTCBB:SFES) which recently merged with TransEnterix Surgical, Inc. , announced today that Todd M. Pope , President and Chief Executive Officer, and Joe Slattery , Executive Vice President and Chief Financial Officer, will

Completes merger with TransEnterix, Inc. , building foundation for growth Closes $30.2 million financing, expanding shareholder base Pre-clinical testing for SurgiBot™ ongoing, expecting 2014 regulatory submissions Strengthens management team, appointing Joseph Slattery at Executive Vice President

SafeStitch Medical Schedules Third Quarter 2013 Results Conference Call for November 12, 2013 MORRISVILLE, N.C., Oct. 31, 2013 — SafeStitch Medical, Inc. (OTCBB: SFES), which recently merged with TransEnterix, Inc., announced today that it plans to release third quarter 2013 financial and operating

Internationally respected surgeon Dr. Michel Gagner completed procedure using fewer incisions

SafeStitch Medical Appoints Joseph P. Slattery as Chief Financial Officer MORRISVILLE, N.C., September 23, 2013 – SafeStitch Medical, Inc. (OTCBB: SFES), which recently merged with TransEnterix, Inc., a development stage medical device company that is pioneering the use of flexible instruments and